OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: International Clinical Psychopharmacology
DOI: 10.1097/yic.0b013e328301a74c
Authors: Amir Garakani, Jose M. Martinez, Sue Marcus, James Weaver, Karl Rickels, Maurizio Fava, Jack Hirschowitz
Institutions: Icahn School of Medicine at Mount Sinai, University of Pennsylvania, Harvard University, Massachusetts General Hospital
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: quetiapine, fluoxetine, major depressive disorder, augmentation therapy, antidepressant combination therapy, onset of action, Montgomery-Asberg Depression Rating Scale, Hamilton Anxiety Rating Scale, Clinical Global Improvement, insomnia, sleep improvement
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2025525296
FWCI: 3.419
Cites: 51
Cited by: 49
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security